S Ruland

Summary

Affiliation: Rush University Medical Center
Country: USA

Publications

  1. ncbi request reprint Acute stroke care in Illinois: a statewide assessment of diagnostic and treatment capabilities
    Sean Ruland
    Department of Neurological Sciences, Section of Cerebrovascular Disease and Neurologic Critical Care, Rush Medical College, Chicago, Ill 60612, USA
    Stroke 33:1334-9. 2002
  2. ncbi request reprint Are cholesterol-lowering medications and antihypertensive agents preventing stroke in ways other than by controlling the risk factor?
    Sean Ruland
    Center for Stroke Research and Section of Cerebrovascular Disease and Neurological Critical Care, Department of Neurological Sciences, Rush Medical College, 1645 West Jackson, Suite 400, Chicago, IL 60612, USA
    Curr Neurol Neurosci Rep 3:21-6. 2003
  3. ncbi request reprint Awareness, treatment, and control of vascular risk factors in African Americans with stroke
    S Ruland
    Department of Neurology, Rush University, Chicago, IL 60612, USA
    Neurology 60:64-8. 2003
  4. ncbi request reprint Are cholesterol-lowering medications and antihypertensive agents preventing stroke in ways other than by controlling the risk factor?
    Sean Ruland
    Center for Stroke Research and Section of Cerebrovascular Disease and Neurological Critical Care, Department of Neurological Sciences, Rush Medical College, 1645 West Jackson, Suite 400, Chicago, IL 60612, USA
    Curr Atheroscler Rep 5:38-43. 2003
  5. ncbi request reprint Predictors of recurrent stroke in African Americans
    S Ruland
    Department of Neurology and Rehabilitation, University of Illinois at Chicago, Chicago, IL 60612, USA
    Neurology 67:567-71. 2006
  6. ncbi request reprint Safety of clopidogrel and aspirin for stroke prevention: implications of the CHARISMA trial
    Sean Ruland
    Section of Cerebrovascular Disease and Neurologic Critical Care, Department of Neurology and Rehabilitation, University of Illinois at Chicago, Chicago, Illinois 60612, USA
    Drug Saf 31:449-58. 2008
  7. ncbi request reprint Cerebral autoregulation and blood pressure lowering
    Sean Ruland
    Hypertension 49:977-8. 2007
  8. ncbi request reprint Impact of obesity and the metabolic syndrome on risk factors in African American stroke survivors: a report from the AAASPS
    Sean Ruland
    Department of Neurology and Rehabilitation, University of Illinois at Chicago, 60612, USA
    Arch Neurol 62:386-90. 2005
  9. ncbi request reprint Stroke in Black Americans
    Sean Ruland
    Department of Neurology and Rehabilitation, University of Illinois at Chicago, 912 S Wood Street, Room 855N, mailcode 796, Chicago, IL 60612, USA
    Curr Cardiol Rep 7:29-33. 2005
  10. ncbi request reprint Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: randomised controlled trial
    Michael E Farkouh
    Cardiovascular Clinical Research Center, New York University School of Medicine, 530 First Avenue, New York, NY 10016, USA
    Lancet 364:675-84. 2004

Detail Information

Publications13

  1. ncbi request reprint Acute stroke care in Illinois: a statewide assessment of diagnostic and treatment capabilities
    Sean Ruland
    Department of Neurological Sciences, Section of Cerebrovascular Disease and Neurologic Critical Care, Rush Medical College, Chicago, Ill 60612, USA
    Stroke 33:1334-9. 2002
    ..To define areas for quality improvement in acute stroke care, a statewide assessment of preparedness for acute stroke diagnosis and treatment was carried out among 202 acute receiving hospitals in Illinois...
  2. ncbi request reprint Are cholesterol-lowering medications and antihypertensive agents preventing stroke in ways other than by controlling the risk factor?
    Sean Ruland
    Center for Stroke Research and Section of Cerebrovascular Disease and Neurological Critical Care, Department of Neurological Sciences, Rush Medical College, 1645 West Jackson, Suite 400, Chicago, IL 60612, USA
    Curr Neurol Neurosci Rep 3:21-6. 2003
    ..We review the mounting evidence that suggests that statins and ACE inhibitors have so-called pleiotropic effects that may lead to stroke prevention...
  3. ncbi request reprint Awareness, treatment, and control of vascular risk factors in African Americans with stroke
    S Ruland
    Department of Neurology, Rush University, Chicago, IL 60612, USA
    Neurology 60:64-8. 2003
    ..To investigate control of risk factors in African American patients with previous stroke...
  4. ncbi request reprint Are cholesterol-lowering medications and antihypertensive agents preventing stroke in ways other than by controlling the risk factor?
    Sean Ruland
    Center for Stroke Research and Section of Cerebrovascular Disease and Neurological Critical Care, Department of Neurological Sciences, Rush Medical College, 1645 West Jackson, Suite 400, Chicago, IL 60612, USA
    Curr Atheroscler Rep 5:38-43. 2003
    ..We review the mounting evidence that suggests that statins and ACE inhibitors have so-called pleiotropic effects that may lead to stroke prevention...
  5. ncbi request reprint Predictors of recurrent stroke in African Americans
    S Ruland
    Department of Neurology and Rehabilitation, University of Illinois at Chicago, Chicago, IL 60612, USA
    Neurology 67:567-71. 2006
    ..Stroke incidence and mortality are disproportionately higher among African Americans than among whites...
  6. ncbi request reprint Safety of clopidogrel and aspirin for stroke prevention: implications of the CHARISMA trial
    Sean Ruland
    Section of Cerebrovascular Disease and Neurologic Critical Care, Department of Neurology and Rehabilitation, University of Illinois at Chicago, Chicago, Illinois 60612, USA
    Drug Saf 31:449-58. 2008
    ..Recent and ongoing studies are seeking to better define the roles of different antiplatelet regimens in preventing recurrent stroke...
  7. ncbi request reprint Cerebral autoregulation and blood pressure lowering
    Sean Ruland
    Hypertension 49:977-8. 2007
  8. ncbi request reprint Impact of obesity and the metabolic syndrome on risk factors in African American stroke survivors: a report from the AAASPS
    Sean Ruland
    Department of Neurology and Rehabilitation, University of Illinois at Chicago, 60612, USA
    Arch Neurol 62:386-90. 2005
    ..The rates of obesity and the metabolic syndrome and the impact on traditional vascular risk factors in African American stroke survivors are unknown...
  9. ncbi request reprint Stroke in Black Americans
    Sean Ruland
    Department of Neurology and Rehabilitation, University of Illinois at Chicago, 912 S Wood Street, Room 855N, mailcode 796, Chicago, IL 60612, USA
    Curr Cardiol Rep 7:29-33. 2005
    ..Therefore, our knowledge regarding stroke in black Americans is somewhat limited. This article provides an update on developments in our understanding regarding stroke in this at-risk population...
  10. ncbi request reprint Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: randomised controlled trial
    Michael E Farkouh
    Cardiovascular Clinical Research Center, New York University School of Medicine, 530 First Avenue, New York, NY 10016, USA
    Lancet 364:675-84. 2004
    ....
  11. ncbi request reprint Aspirin and ticlopidine for prevention of recurrent stroke in black patients: a randomized trial
    Philip B Gorelick
    Department of Neurologic Sciences, Rush Medical College, Chicago, IL 60612, USA
    JAMA 289:2947-57. 2003
    ..Blacks are disproportionately affected by stroke, and they are about 2 times more likely than most other individuals in the United States to die of or experience stroke...
  12. ncbi request reprint IMAGES and FAST-MAG: magnesium for acute ischaemic stroke
    Philip B Gorelick
    Department of Neurology and Rehabilitation, University of Illinois College of Medicine, Illinois, USA
    Lancet Neurol 3:330. 2004
  13. ncbi request reprint A comparison of the blood pressure changes of lumiracoxib with those of ibuprofen and naproxen
    Michael E Farkouh
    Clinical Trials Unit, Mount Sinai Cardiovascular Institute, New York, NY 10029, USA
    J Clin Hypertens (Greenwich) 10:592-602. 2008
    ..0001) and +0.43 with lumiracoxib compared with +1.80 mm Hg with naproxen (P<.0001). In conclusion, the use of lumiracoxib and traditional NSAIDs results in differing BP changes; these might be of clinical relevance...